Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PGEN | US
-0.07
-6.82%
Healthcare
Biotechnology
30/06/2024
04/10/2024
0.90
0.92
0.94
0.90
Precigen Inc. discovers and develops the next generation of gene and cellular therapies in the United States. The company operates through two segments Biopharmaceuticals and Exemplar. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive technologies. In addition the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15 a gene that enhances functional characteristics of immune cells; Sleeping Beauty a non-viral transposon/transposase system; AttSite recombinases which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform a library of engineered adenovector serotypes; and Lactococcus lactis a food-grade bacterium. Additionally it provides RheoSwitch Therapeutic System an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen Inc. has collaboration and license agreements with Alaunos Therapeutics Inc.; Intrexon Energy Partners LLC; and Intrexon Energy Partners II LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen Inc. in January 2020. Precigen Inc. was founded in 1998 and is headquartered in Germantown Maryland.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
57.5%1 month
62.0%3 months
76.6%6 months
67.5%-
9.14
6.42
0.15
0.09
-3.31
60.10
-
-88.58M
263.38M
263.38M
-
-3.67K
-
-59.40
-129.32
17.64
7.50
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.15
Range1M
0.20
Range3M
1.03
Rel. volume
0.74
Price X volume
570.61K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Lexeo Therapeutics Inc. Common Stock | LXEO | Biotechnology | 8.66 | 286.31M | -0.69% | n/a | 6.58% |
Design Therapeutics Inc. Common Stock | DSGN | Biotechnology | 5 | 283.10M | 0.60% | n/a | 1.03% |
Rigel Pharmaceuticals Inc | RIGL | Biotechnology | 16.04 | 282.22M | -3.32% | n/a | -201.68% |
Abeona Therapeutics Inc | ABEO | Biotechnology | 6.46 | 279.81M | 3.69% | n/a | 31.63% |
Akebia Therapeutics Inc | AKBA | Biotechnology | 1.33 | 279.68M | -0.75% | n/a | -309.96% |
Nkarta Inc | NKTX | Biotechnology | 3.92 | 279.65M | -6.00% | n/a | 18.88% |
Editas Medicine Inc | EDIT | Biotechnology | 3.38 | 278.77M | 4.97% | n/a | 16.68% |
uniQure N.V | QURE | Biotechnology | 5.65 | 275.14M | 24.45% | n/a | 550.36% |
Vanda Pharmaceuticals Inc | VNDA | Biotechnology | 4.63 | 269.88M | 0.87% | n/a | 1.55% |
Genfit SA | GNFT | Biotechnology | 5.3861 | 268.80M | 4.67% | 13.90 | 104.08% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
CPI Card Group Inc | PMTS | Building Products & Equipment | 23.62 | 261.38M | 4.61% | 17.90 | -621.78% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 13.5 | 219.91M | 1.89% | 8.52 | 39.79% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 31.64 | 90.86M | -0.32% | 5.47 | 19.82% |
Saga Communications Inc | SGA | Broadcasting - Radio | 14 | 87.66M | -1.27% | 14.62 | 7.10% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 7.64 | 83.40M | -1.93% | n/a | 58.43% |
Urban One Inc | UONEK | Broadcasting - Radio | 1.02 | 57.65M | -4.67% | n/a | 268.43% |
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.89 | 19.79M | -2.50% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 1.0599 | 19.14M | -0.93% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.695 | 8.47M | -4.15% | n/a | 16.03% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.6199 | 5.90M | 6.82% | n/a | 19.98% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -3.31 | 0.76 | Cheaper |
Ent. to Revenue | 60.10 | 3,674.48 | Cheaper |
PE Ratio | - | 38.01 | - |
Price to Book | 6.42 | 14.10 | Cheaper |
Dividend Yield | - | 2.22 | - |
Std. Deviation (3M) | 76.56 | 74.67 | Par |
Debt to Equity | 0.15 | -1.82 | Expensive |
Debt to Assets | 0.09 | 0.26 | Cheaper |
Market Cap | 263.38M | 3.73B | Emerging |